Concepedia
Statistics
Publications
55
Citations
3.9K
H-Index
33
Active since
2004
Affiliations
Ben-Gurion University of the Negev(Current)
Soroka Medical Center
Memorial Sloan Kettering Cancer Center
Tianjin Medical University
German Cancer Research Center
Moshe Elkabets is an author at Ben-Gurion University of the Negev specializing in oncology, medicine, and molecular oncology.
Publications per year
2004–2025
mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in <i>PIK3CA</i> -Mutant Breast Cancer
Moshe Elkabets, Sadhna Vora, Dejan Juric et al. · Science Translational Medicine · 2013 · 347 citations · Full text
Medicine, Oncology, Pharmacology +17
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric et al. · Cancer Cell · 2015 · 340 citations · Full text
Medicine, Cancer Biology, Oncology +17
IL‐1β regulates a novel myeloid‐derived suppressor cell subset that impairs NK cell development and function
Moshe Elkabets, Vera S. G. Ribeiro, Charles A. Dinarello et al. · European Journal of Immunology · 2010 · 313 citations · Full text
Medicine, Immunology, Oncology +17
Interleukin-1β–Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen–Induced Tumors
Yakov Krelin, Elena Voronov, Shahar Dotan et al. · Cancer Research · 2007 · 274 citations · Full text
Medicine, Oncology, Pathology +17
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D
Eneda Toska, Hatice U. Osmanbeyoglu, Pau Castel et al. · Science · 2017 · 269 citations · Full text
Medicine, Molecular Biology, Oncology +15
1–5 of 55